Proove Genomics Inc.的动态

???? Happy Global Biotech Week!???? As we celebrate Global Biotech Week, we are reflecting on how biotechnology continues to shape the future of healthcare, innovation, and research across the globe. From improving patient outcomes to driving forward groundbreaking advancements in medical devices, this field is constantly evolving—and DIA Labs is proud to be part of this journey. At DIA Labs, we are committed to pushing the boundaries of what’s possible in healthcare technology. Our latest work with **AirSense**, an innovative asthma monitoring device, is just one of the many ways we’re striving to make a meaningful impact. By working alongside healthcare providers, researchers, and thought leaders in the biotechnology space, we are aiming to deliver life-changing solutions to patients around the world. This week, let’s celebrate the incredible talent, innovation, and collaboration that defines the biotech industry. Here’s to creating a healthier, more sustainable future for all! #GlobalBiotechWeek #InnovationInHealthcare #Biotechnology #DIALabs #MedicalDevices #AsthmaResearch #HealthcareTech #ClinicalResearch

While new technologies and smart solutions play a pivotal role in transforming the #clinicaltrial landscape, collaboration is also a key aspect of innovation. Thermo Fisher Scientific’s newly opened Innovation Lab in Center Valley, PA is designed to foster a culture of co-creation and strategic thinking to maximize the impact of innovation and advance clinical trial research. Sarah Blake Englert, senior director of innovation and program management, shared her insights on why the lab was designed with rapid innovation in mind and how the outcomes generated from the lab are expected to have a significant impact on clinical trials – from more accessible trials for participants to getting life-saving therapies to patients, faster. Learn more in this article by Outsourcing-Pharma: https://spr.ly/6044br0kg

Orthocell Ltd CEO & MD Paul Anderson joined Australia's biotech and medtech leaders at the inaugural National Biotech and Medtech Development and Commercialisation Summit 2024 in Canberra this week. The summit brought together over 100 of Australia's leading industry figures, policy experts, and innovators to address critical challenges in commercialising Australian medical innovations. As a Company committed to advancing regenerative medicine – and the wider life sciences sector – Orthocell was excited to be part of this national conversation on strengthening Australia's position in the global biotech landscape. Key summit themes included protecting Australia's sovereign capabilities, accelerating commercialisation pathways, optimising capital deployment, and developing our future workforce – all crucial elements in bridging Australia's research-to-market gap. Following the summit, Orthocell was the only company invited to present a case study at the parliamentary function, where Paul showcased our journey in bringing Australian innovations to global markets. Thank you to AusBiotech and MTPConnect for organising this important industry event. We look forward to contributing to the sector's growth and bringing more Australian innovations to global markets.? $OCC #biotech #medtech #innovation #healthcare #regenerativemedicine #leadership?

As I prepare for my annual trip to San Francisco to be a part of the excitement around the J.P. Morgan Healthcare Conference, I eagerly anticipate reconnecting with business partners, customers, and investors alike. My first trip to this city was back in 2005, and I have been coming ever since. One year that I vividly remember was the 2013 conference, where I discussed with early investors the idea of creating a company focused exclusively on biosimilars, envisioning the building of a modern, state-of-the-art facility long before it was needed. Now, 12 years later and with nearly $2 billion invested, I reflect on the incredible progress we have made and the journey of the company we named Alvotech. Annual events often serve as markers of growth and maturation. Just as we celebrate our children's birthdays or other yearly traditions, for me, Alvotech's growth is intertwined with the memories of my trips to San Francisco. Each year, the conversations about our venture have evolved, reflecting our challenges, achievements and future aspirations. But each year represents a step in our evolution. Today, we have launched two products in global markets, with multiple launches on the near-term horizon. We have an expansive pipeline in development and a top-notch team of scientists and professionals that work tirelessly to provide the world with biosimilars, a crucial component in the sustainability of healthcare systems. The importance of biosimilars cannot be overstated—they provide affordable alternatives to biologic drugs, significantly reducing healthcare costs and increasing patient access to essential treatments. Beyond affordability, biosimilars drive innovation by introducing much-needed competition into the market. This competition fuels a dynamic ecosystem of innovation, a vibrant energy that is palpable in the many companies that converge in San Francisco every January. As I look forward to next week, I am filled with pride in what we have accomplished and excitement for the future. And, of course, I am hoping for good weather in San Francisco! ?? #biosimilars #biologics #innovation #Alvotech #JPM2025 Image: ?Justin Mier

While new technologies and smart solutions play a pivotal role in transforming the #clinicaltrial landscape, collaboration is also a key aspect of innovation. Thermo Fisher Scientific’s newly opened Innovation Lab in Center Valley, PA is designed to foster a culture of co-creation and strategic thinking to maximize the impact of innovation and advance clinical trial research. Sarah Blake Englert, senior director of innovation and program management, shared her insights on why the lab was designed with rapid innovation in mind and how the outcomes generated from the lab are expected to have a significant impact on clinical trials – from more accessible trials for participants to getting life-saving therapies to patients, faster. Learn more in this article by Outsourcing-Pharma: https://spr.ly/6043br0k5

The second annual Top of Mind Summit: Life Sciences took place on September 9-10, 2024, at the Center for Connected Medicine (CCM) at UPMC. Organized by UPMC Enterprises, the conference gathered around 100 thought leaders from health care, biotechnology, government policy, pharma, and the life sciences. They discussed and debated both current and emerging challenges and opportunities within the life sciences and health care ecosystems. This year's Summit focused on the intersection of technological innovation and patient care, highlighting how successful collaborations in the life sciences can drive the rapid evolution of new health care models that enable life changing medicine. Key topics included leveraging real-world data and artificial intelligence to enhance therapeutic development, transform clinical trial design and execution, and improve the efficiency and equity of health care delivery and innovative therapeutics. Panel discussions throughout the event emphasized the increasing importance of partnerships between health care systems, academia, and industry in fostering ongoing innovation and advancing health care access and equity. Download the Summit recap report for more about the event. https://lnkd.in/ed6B5buS

Join our third Transforming Science Day on 25th February where we’ll be showcasing our unique culture of innovation and hear from industry leaders and scientists about exciting career paths in pharma R&D. This flagship event, developed and funded by Boehringer Ingelheim, is all about winning for patients.?? It features champions in science who have made significant advancements for patients worldwide, aspiring scientific talents aiming for the next big breakthrough, and the patients who benefit from these innovations.? You can hear firsthand from scientists about their career journeys and experiences in the research and development of scientific breakthroughs. You’ll also learn how we work with the life sciences community to advance science and improve patients' lives.? With thousands of people from across the world joining the first two events in Boston and London, this year's event in Heidelberg, Germany, promises to be even more impactful.? ?? Speakers include:? - Scientists working in areas such as discovery research, artificial intelligence and more? - Patient advocates and a CEO representing millions of patients worldwide? - Influential leaders from across academia?? If you're a scientist, or simply interested in learning more about what a fulfilling and impactful career can look like working in pharma R&D, don’t miss out!?To attend virtually, register here: https://lnkd.in/e6AKyetP? Let's make a difference together! ??? #Science #ResearchAndDevelopment #First4Patients

The "Deep Dive Journey Life Sciences" event from November 25-28, 2024, offers Swiss companies an immersive exploration of Bavaria's thriving life sciences ecosystem.?? Delegates will visit top biotech clusters and innovation hubs, including BioM, IZB in Martinsried, BioPark Regensburg and Medical Valley in Erlangen, gaining insights into Bavaria's biotech advancements and research collaborations.?? This journey provides unparalleled networking opportunities with leaders from pioneering Bavarian companies and institutions, including Roche Diagnostics, Novartis, FUJIFILM medwork GmbH and the Fraunhofer IIS, fostering potential partnerships and exchange of best practices. ?? With Bavaria and Switzerland both recognized as global biotech powerhouses, this initiative underscores their shared commitment to advancing biotech innovation. Bavaria’s structured support system, including funding, infrastructure, and an educated workforce, complements the Swiss focus on commercializing breakthrough therapies, particularly in areas like orphan drugs and advanced diagnostics. This journey exemplifies a concerted effort to link Swiss and Bavarian expertise, which could open doors for impactful cross-border collaborations in life sciences. ?? More about Health, MedTech and Life Sciences in Bavaria: https://lnkd.in/dyGe5qfQ ? Reach out to Anna Damerow und Kaori Yamaguchi-Humpert for questions and further information. ? #successinbavaria #deepdivejourney #lifesciences IZB - Innovation and Start-up Center Biotechnology I BioPark Regensburg GmbH I BioM Biotech Cluster Development GmbH I Bayern Innovativ GmbH I Gesundheit bei Bayern Innovativ I Biomedical Center Munich I Universit?tsklinikum Regensburg I Medical Valley EMN e. V.

Recently, our team at UPMC Enterprises hosted the second annual Top of Mind Summit: Life Sciences at the Center for Connected Medicine at UPMC, bringing together leaders from health care, biotechnology, policy, pharma, and life sciences for transformative discussions on accelerating health care models with technological innovation, patient-centered care, and strategic collaborations. During the event, I joined leaders from Memorial Hermann Health System, UPMC Health Plan, and the Arctos Foundation for a keynote discussion focused on the escalating costs of novel therapeutics and the need for sustainable reimbursement models. For insights from our panel, “The Evolving Health Care Landscape,” along with additional highlights from the summit, you can access the recap report here.?https://lnkd.in/e-KHJYMW

The "Deep Dive Journey Life Sciences" brought Swiss companies into the heart of Bavaria's thriving biotech and life sciences ecosystem. From exploring leading innovation hubs like BioM Biotech Cluster Development GmbH, the IZB - Innovation and Start-up Center Biotechnology in Martinsried, BioPark Regensburg GmbH, and the Medical Valley in Erlangen to engaging with pioneering companies such as Roche Diagnostics, FUJIFILM medwork GmbH, and Novartis, participants gained unparalleled insights into Bavaria's industry landscape.?? The first day set the tone for collaboration, starting with impactful opening remarks from Verena Stübner (Handelskammer D-CH), Eros Robbiani (Swiss General Consulate), and Dr. Lukas Julian Keller (Swiss Business Hub Germany). Highlights included presentations on groundbreaking therapies from Immunic Therapeutics and advanced cell culture solutions from PELOBiotech GmbH, along with site visits to the Biomedical Center Munich and Labvantage - Biomax GmbH.?? Networking opportunities were abundant, with a standout moment being the dinner officially opened by Tobias Gotthardt fostering valuable connections and discussions. This journey emphasized the shared strengths of Bavaria and Switzerland as global biotech leaders, showcasing their commitment to advancing innovation in areas such as orphan drugs, advanced diagnostics, and life sciences research. It served as a powerful reminder of the potential for cross-border collaborations to shape the future of healthcare. More about Health, MedTech and Life Sciences in Bavaria: https://lnkd.in/dcku9sZP Bayern Innovativ GmbH I Gesundheit bei Bayern Innovativ I Universit?tsklinikum Regensburg I Medical Valley EMN e. V. #LifeSciences #Bavaria #Switzerland #Innovation #Biotech #Collaboration